SHAH, MANISHMD NPI 1962792986 Clinician
Pain Management · LIMERICK, PA
- NORTHSTAR ANESTHESIA OF PENNSYLVANIA LLC — DARBY, PA
- NOVACARE OUTPATIENT REHABILITATION EAST, INC. — COLLEGEVILLE, PA
- PHOENIX REHABILITATION AND HEALTH SERVICES INC — CRANBERRY TOWNSHIP, PA
- SE PAIN MANAGEMENT, LTD — ABINGTON, PA
Group affiliation since 2019
The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.
Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.
- Payment, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Volume over five years — discrete yearly counts, no rate
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | premium | premium | premium | premium |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| 96127 | Assessment of emotional or behavioral problems | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | premium | premium | premium | premium |
| 80307 | Testing for presence of drug, by chemistry analyzers | premium | premium | premium | premium |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | premium | premium | premium | premium |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | premium | premium | premium | premium |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 98980 | Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | premium | premium | premium | premium |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | premium | premium | premium | premium |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | premium | premium | premium | premium |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | premium | premium | premium | premium |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 62323 | Injection of substance into lower spine canal using imaging guidance | premium | premium | premium | premium |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | premium | premium | premium | premium |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | premium | premium | premium | premium |
| 20553 | Injection of trigger points, 3 or more muscles | premium | premium | premium | premium |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | premium | premium | premium | premium |
| J1030 | Injection, methylprednisolone acetate, 40 mg | premium | premium | premium | premium |
| 64628 | Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.